KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherFurniture, Fixtures and OtherGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Other Gross PP&E Adjustments (2016 - 2026)

Boston Scientific's Other Gross PP&E Adjustments history spans 18 years, with the latest figure at -$547.0 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 80.53% to -$547.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$547.0 million, a 80.53% decrease, with the full-year FY2025 number at $3.2 billion, up 0.54% from a year prior.
  • Other Gross PP&E Adjustments hit -$547.0 million in Q1 2026 for Boston Scientific, down from $3.2 billion in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for BSX hit a ceiling of $3.2 billion in Q4 2025 and a floor of -$547.0 million in Q1 2026.
  • Historically, Other Gross PP&E Adjustments has averaged $95.8 million across 5 years, with a median of -$289.0 million in 2024.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 1149.5% in 2024 and later crashed 80.53% in 2026.
  • Tracing BSX's Other Gross PP&E Adjustments over 5 years: stood at -$248.0 million in 2022, then dropped by 20.56% to -$299.0 million in 2023, then skyrocketed by 1149.5% to $3.1 billion in 2024, then rose by 0.54% to $3.2 billion in 2025, then tumbled by 117.34% to -$547.0 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for BSX at -$547.0 million in Q1 2026, $3.2 billion in Q4 2025, and -$347.0 million in Q3 2025.